Phosphagenics CEO steps down

Monday, 22 July, 2013

Dr Esra Ogru, CEO of Phosphagenics (ASX: POH), handed in her resignation as a director of the company effective as of last Thursday 18 July 2013.

The Phosphagenics board suspended Esra Ogru on 1 July, after it discovered apparent irregular transactions in the company’s invoicing and accounting records.

The company expects to announce the key findings of an independent investigation on Wednesday 24 July 2013.

Phosphagenics’ shares were trading at $0.105 at about 3 pm on Monday.

Australian researchers have developed a portable point-of-care test that detects four common...

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

The success of a cervical cancer elimination program has led to the signing of a memorandum of...

Content from other channels on our network

Engineers Australia reflects on World Engineering Day 2026

Mineral resources stocktake reinforces Australia's strengths

SPC Global to close facility in Vic under demand-led strategy

CSIRO and AMRF Connect partner on advanced manufacturing program

Circular connectors: small components playing a big role in Australian industry

How Floor Scrubbers Support Infection Prevention In Healthcare

The AI Revolution in Clinical Trials: New Research Reveals Why Industry Leaders Are Making the Shift Now

Hospital’s "recovery at work" collaborative approach proves a winning model

Medicine shortages are testing Australia's health system and clinicians need national support

A Day in the Life of a home support clinical care team manager

Australia Post sets 2030 emissions targets

UNSW tracks groundwater recharging: study

$320m to power Western Sydney International Airport

Water-repellent membrane advances desalination

Aussie-made remote telemetry unit tech expands into NZ